SPRING is here and while many of us are jumping for joy, it is also the time of year when lots of people come down with a bug ...
Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug ...
Scientists have taken an important step toward the development of a potential new treatment for treating Shiga ...
By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...
A 2025 report from the Asthma and Allergy Foundation of America has ranked Birmingham 39th out of the top 100 cities for the ...
Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results